SEI Investments’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-29,106
| Closed | -$863K | – | 2732 |
|
|
2023
Q4 | $863K | Sell |
29,106
-164,596
| -85% | -$3.28M | ﹤0.01% | 1923 |
|
|
2023
Q3 | $3.07M | Buy |
193,702
+1,263
| +0.7% | +$21K | 0.01% | 1389 |
|
|
2023
Q2 | $3.63M | Buy |
192,439
+147,318
| +326% | +$1.74M | 0.01% | 1354 |
|
|
2023
Q1 | $173K | Buy |
+45,121
| New | +$192K | ﹤0.01% | 2506 |
|
|
2019
Q2 | – | Sell |
-540
| Closed | -$1K | – | 2839 |
|
|
2019
Q1 | $1K | Buy |
+540
| New | +$2.34K | ﹤0.01% | 2884 |
|
|
2018
Q3 | – | Sell |
-1,200
| Closed | -$12K | – | 3550 |
|
|
2018
Q2 | $12K | Sell |
1,200
-87
| -7% | -$917 | ﹤0.01% | 2956 |
|
|
2018
Q1 | $14K | Sell |
1,287
-54
| -4% | -$533 | ﹤0.01% | 2775 |
|
|
2017
Q4 | $9K | Buy |
1,341
+46
| +4% | +$284 | ﹤0.01% | 2833 |
|
|
2017
Q3 | $10K | Buy |
1,295
+95
| +8% | +$631 | ﹤0.01% | 2697 |
|
|
2017
Q2 | $9K | Buy |
1,200
+700
| +140% | +$3.2K | ﹤0.01% | 2617 |
|
|
2017
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 2741 |
|
|
2016
Q4 | $1K | Hold |
500
| – | – | ﹤0.01% | 2849 |
|
|
2016
Q3 | $1K | Buy |
500
+471
| +1,624% | +$1.37K | ﹤0.01% | 2770 |
|
|
2016
Q2 | $0 | Buy |
+29
| New | +$182 | ﹤0.01% | 2787 |
|
|
2015
Q4 | – | Sell |
-41,052
| Closed | -$394K | – | 2723 |
|
|
2015
Q3 | $394K | Buy |
+41,052
| New | +$600K | ﹤0.01% | 1373 |
|
Other funds holding IMGN
SEI Investments's IMGN Position: Q1 2024 in Review
SEI Investments sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 29,106 shares — an estimated $863K sold.
SEI Investments first reported a position in IMGN in Q3 2015 and held it in 15 quarters. The position peaked at $3.63M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- SEI Investments reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- SEI Investments sold 29,106 Immunogen Inc shares in Q1 2024, an estimated $863K.
- SEI Investments first reported a position in Immunogen Inc in Q3 2015 and held it in 15 quarters.
- SEI Investments's Immunogen Inc position peaked at $3.63M in Q2 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on SEI Investments's 13F filing for Q1 2024, filed 7 May 2024.